Bareskrim Suspects Owners Of CV Samudera Chemicals In Cases Of Accounting For Acute Straights

The search on CV Samudera Chemical on Monday, October 31. From there, a barbuk was found mixing PG. (ANTARA-Andi Firdaus)

The Criminal Investigation Unit of the National Police has named the owner of CV Samudera Chemical with the initials E as an individual suspect in the case of acute kidney failure in children. The figure is also being hunted because he has never met two summons for examination.

"Yes (the suspect, ed) we have already held a case to become a suspect," said the Director of Certain Crimes at the National Police Criminal Investigation Agency Brigadier General Pipit Rismanto when contacted, Wednesday, November 23.

The determination of E as a suspect is said to coincide with CV Samudera Chemical and PT Afi Farma. The three parties are considered responsible for the rampant kidney failure in children.

"The criminal act has been seen, investigators have found it. There are clues that say they (the pharmaceutical company, red) were bought from there (CV SC). That's clear," he said.

Meanwhile, suspect E seemed to have disappeared after the police found dozens of drums of sirop medicinal raw materials contaminated with glycol (EG) ethylene glycol (DEG) and dietilen glycol (DEG) exceeding the threshold.

Pipt said finding the whereabouts of suspect E was not an easy matter. Because, there is only a small amount of information obtained.

Moreover, investigators also do not know the characteristics of the suspect. So, currently gathering information and clues continues.

"It's not easy, we're looking for this, it can't be that easy. Investigators have never met, we've never known it," said Pipit.

For information, in the case of acute kidney failure in children, Bareskrim Polri named CV Samudera Chemical and PT Afi Farma as suspects. The two pharmaceutical companies are considered to have committed crimes of producing drugs or distributing pharmaceutical preparations that do not meet standards, both in terms of security and benefit.